Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2020 Publisher: RPH Pharmaceuticals AB, Box 603, 101 32 Stockholm, Sweden
Bettamousse 1mg/g (0.1%) cutaneous foam.
| Pharmaceutical Form |
|---|
|
Cutaneous foam. White, foam mousse. |
1 g of foam contains 1 mg betamethasone (0.1%) as valerate.
Excipients with known effect: Cetyl Alcohol 1.10% w/w, Stearyl alcohol 0.50% w/w and Propylene glycol 2.00% w/w.
For a full list of excipients, see 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Betamethasone |
Betamethasone is a glucocorticoid which is about eight to ten times as active as prednisolone on a weight-for-weight basis. Betamethasone has anti-inflammatory, antipruritic, and vasoconstrictive properties. |
| List of Excipients |
|---|
|
Cetyl alcohol |
Pressurised container.
Aluminium EP-lined Cebal can with Precision valve and clear cover cap, with a net weight of 50 or 100g.
Not all pack sizes may be marketed.
RPH Pharmaceuticals AB, Box 603, 101 32 Stockholm, Sweden
PL 36301/0036
19 April 1996 / 19 April 2001
| Drug | Countries | |
|---|---|---|
| BETTAMOUSSE | Ireland, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
